Last edition
News about Global Pharma
Circle Pharma, a clinical-stage biotech firm developing macrocycle therapeutics for hard-to-treat cancers, has received Orphan Drug Designation from the US FDA for its investigational drug CID-078 targeting small cell lung cancer.
Global Pharma | 20/06/2025 | By Manvi | 144
Marksans Pharma’s UK subsidiary Relonchem has received MHRA approval for Oxybutynin hydrochloride 2.5mg/5ml Oral Solution, strengthening the company’s presence in the UK generics market across key therapeutic areas.
Global Pharma | 19/06/2025 | By Abha | 264
Miltenyi Biotec India, BIRAC Partner to Advance India's Cell and Gene Therapy Ecosystem
The partnership will focus on building local scientific capabilities, CAR-T clinical trials, addressing unmet medical needs and enhancing access through PoC manufacturing centres to strengthen India’s CGT capabilities.
Global Pharma | 19/06/2025 | By Abha | 379
Bayer Seeks US FDA Approval of gadoquatrane for MRI of CNS and Other Body Parts
Bayer has submitted a New Drug Application to the US FDA for gadoquatrane, an investigational MRI contrast agent. If approved, it would offer the lowest gadolinium dose among macrocyclic GBCAs in the US, cutting exposure by 60 percent while maintaining diagnostic efficacy.
Global Pharma | 18/06/2025 | By Abha | 293
BASF Opens New GMP Solution Centre in Michigan
BASF has inaugurated a state-of-the-art GMP Solution Center in Wyandotte, Michigan, reinforcing its commitment to innovation and quality in biopharma and pharmaceutical manufacturing through advanced, customer-centric solutions and rigorous quality standards.
Global Pharma | 18/06/2025 | By Abha | 177
AdventHealth Tampa First in Region to Perform Colorectal Surgery with da Vinci SP Robot
AdventHealth Tampa is now the first hospital in the Tampa Bay region to successfully perform a transabdominal colorectal surgery using the da Vinci SP (single port) robot, taking the next step forward in providing minimally invasive colorectal procedures.
Global Pharma | 17/06/2025 | By Manvi | 101
Lupin, Sino Universal Pharmaceuticals Ink License and Supply Agreement for Tiotropium DPI in China
Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals to commercialise its Tiotropium Dry Powder Inhaler for COPD treatment in China, marking a strategic expansion of its respiratory portfolio in the Chinese market.
Global Pharma | 16/06/2025 | By Manvi | 157
EDA is an organic compound used as a building block in the synthesis of various chemicals, including those used in pharmaceuticals. It is also used as an excipient to help formulate and administer a drug, such as in creams and ointments.
Global Pharma | 16/06/2025 | By Darshana | 231
Safe Group Secures FDA 510(k) Clearance for SpineUp's Frida Solution
Safe Group has announced that SpineUp’s innovative cervical plate, Frida, has received FDA 510(k) clearance, marking a key milestone in its expansion into the North American market.
Global Pharma | 13/06/2025 | By Manvi | 182
MolecuLight i:X Proven Effective in Treating Deep Wound Infections: Taiwan Study
MolecuLight Inc. and its Taiwanese distributor, Healtdeva Company Ltd. , congratulate researchers at Taipei Shuang-Ho Hospital in Taiwan on the publication of groundbreaking findings with MolecuLight.
Global Pharma | 13/06/2025 | By Manvi | 155
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy